Document is current

Any future updates will be listed below

Targeting HDAC8 sensitizes tyrosine kinase inhibitors in the elimination of B-cell acute lymphoblastic leukemia cells through degradation of HIF-1α

Crossref DOI link: https://doi.org/10.1038/s41375-025-02749-6

Published Online: 2025-09-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark